Form 6375 Ks Nepr 0116 - Neprilysin Inhibitor Prior Authorization

Download a blank fillable Form 6375 Ks Nepr 0116 - Neprilysin Inhibitor Prior Authorization in PDF format just by clicking the "DOWNLOAD PDF" button.

Open the file in any PDF-viewing software. Adobe Reader or any alternative for Windows or MacOS are required to access and complete fillable content.

Complete Form 6375 Ks Nepr 0116 - Neprilysin Inhibitor Prior Authorization with your personal data - all interactive fields are highlighted in places where you should type, access drop-down lists or select multiple-choice options.

Some fillable PDF-files have the option of saving the completed form that contains your own data for later use or sending it out straight away.

ADVERTISEMENT

NEPRILYSIN INHIBITOR(ENTRESTO™)
PRIOR AUTHORIZATION
Clear Data
Physician Fax Form
BCBS Kansas REQUIRES that this form be completed by the prescriber. This form is for prospective, concurrent and retrospective reviews.
The following documentation is REQUIRED for prior authorization. Incomplete forms will be returned for additional information.
To ensure you are submitting this form correctly, you can complete and submit it directly to us online at
For formulary information, please visit the Blue Cross and Blue Shield of Kansas website at
PATIENT INFORMATION
Today’s Date:
Patient Name (First):
Last:
M:
DOB (mm/dd/yyyy):
Patient Address:
City, State, Zip:
Patient Telephone:
INSURANCE INFORMATION
Member ID Number:
Group Number:
PHYSICIAN/CLINIC INFORMATION
Prescriber Name:
Physician NPI#:
Specialty:
Contact Name:
Clinic Name:
Clinic Address:
City, State, Zip:
Phone #:
Secure Fax #:
(PA decisions will be sent here)
PLEASE ATTACH ANY ADDITIONAL INFORMATION THAT SHOULD BE CONSIDERED WITH THIS REQUEST
Patient Diagnosis
– ICD code plus description:
Medication Requested:
Strength
:
Dosing Schedule:
Quantity per Month:
1.
Does the patient have NYHA Class II – IV heart failure? ........................................................................................
Yes
No
2.
What is the baseline or current left ventricular ejection fraction: _____________________________________
3.
Is the patient currently on a beta blocker? .............................................................................................................
Yes
No
If no, does the patient have an intolerance or contraindication to a beta blocker? ........................................
Yes
No
If yes, please explain: _____________________________________________________________
4.
Will the patient be taking Entresto in combination with an ACE inhibitor or aliskerin? ............................................
Yes
No
5.
Does the patient have a history of angioedema related to previous ACE inhibitor or ARB therapy? ......................
Yes
No
6.
Is the patient pregnant? ..........................................................................................................................................
Yes
No
7.
Please list all reasons for selecting the requested medication, strength, and quantity over alternatives (e.g. contraindications,
allergies or history of adverse drug reactions to alternatives, lower dose has been tried):
8.
Please list all other medications the patient is currently taking for treatment of this diagnosis.
9.
Please list all medications the patient has previously tried and failed for treatment of this diagnosis. (Please specify if the
patient has tried brand-name products, generic products or over-the-counter products.)
____________________________
Date: ___________
___________________________
Date: __________
___________________________
Date: ___________
___________________________
Date: __________
Please fax or mail this form to:
CONFIDENTIALITY NOTICE: This communication is intended only for the
Prime Therapeutics LLC
use of the individual entity to which it is addressed, and may contain
Clinical Review Department
information that is privileged or confidential. If the reader of this message is
1305 Corporate Center Drive
not the intended recipient, you are hereby notified that any dissemination,
Eagan, Minnesota 55121
distribution or copying of this communication is strictly prohibited. If you
have received this communication in error, please notify the sender
TOLL FREE
immediately by telephone at 866.469.5660, and return the original message
Fax: 877.480.8130
Phone: 866.469.5660
to Prime Therapeutics via U.S. Mail. Thank you for your cooperation.
Blue Cross and Blue Shield of Kansas is an independent licensee of the Blue Cross Blue Shield Association. BLUE CROSS
, BLUE SHIELD
and the Cross and Shield Symbols are registered service marks of the Blue Cross Blue Shield Association, an association of independent Blue Cross
and Blue Shield Plans. Prime Therapeutics LLC is an independent limited liability company providing pharmacy benefit management services.
PRIME THERAPEUTICS LLC 11/15
6375 KS NEPR 0116

ADVERTISEMENT

00 votes

Related Articles

Related forms

Related Categories

Parent category: Business
Go